Polybutylcyanoacrylate nanocarriers as promising targeted drug delivery systems

References

• Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 2012;161:505–22
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy B, Karanam V, Chellan VR, et al. Polymersomes as an effective drug delivery system for glioma – a review. J Drug Target 2014;22:469–77
   PubMed Web of Science ®Google Scholar
• Couvreur P, Kante B, Roland M, et al. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J Pharm Pharmacol 1979;31:331–2
   PubMed Web of Science ®Google Scholar
• O'Sullivan C, Birkinshaw C. Hydrolysis of poly (n-butylcyanoacrylate) nanoparticles using esterase. Polym Degrad Stabil 2002;78:7–15
   Web of Science ®Google Scholar
• Scherer D, Robinson JR, Kreuter J. Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles. Int J Pharm 1994;101:165–8
   Web of Science ®Google Scholar
• Sullivan CO, Birkinshaw C. In vitro degradation of insulin-loaded poly (n-butylcyanoacrylate) nanoparticles. Biomaterials 2004;25:4375–82
   PubMed Web of Science ®Google Scholar
• Jin X, Xu Y, Shen J, et al. Chitosan-glutathione conjugate-coated poly(butyl cyanoacrylate) nanoparticles: promising carriers for oral thymopentin delivery. Carbohydr Polym 2011;86:51–7
   Web of Science ®Google Scholar
• Tan R, Niu M, Zhao J, et al. Preparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targeting. J Drug Target 2014;22:509–17
   PubMed Web of Science ®Google Scholar
• Wang C, Huang L, Hou L, et al. Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model. Brain Res 2009;1261:91–9
   PubMed Web of Science ®Google Scholar
• Wohlgemuth M, Mayer C. Pulsed field gradient NMR on polybutylcyanoacrylate nanocapsules. J Colloid Interface Sci 2003;260:324–31
   PubMed Web of Science ®Google Scholar
• Gao H, Wang JY, Shen XZ, et al. Preparation of magnetic polybutylcyanoacrylate nanospheres encapsulated with aclacinomycin A and its effect on gastric tumor. World J Gastroenterol 2004;10:2010–13
   PubMed Web of Science ®Google Scholar
• Behan N, Birkinshaw C, Clarke N. Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation. Biomaterials 2001;22:1335–44
   PubMed Web of Science ®Google Scholar
• Hansali F, Poisson G, Wu M, et al. Miniemulsion polymerizations of n-butyl cyanoacrylate via two routes: towards a control of particle degradation. Colloid Surf B 2011;88:332–8
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Santhi K, et al. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Brain Res 2008;1200:159–68
   PubMed Web of Science ®Google Scholar
• Bootz A, Russ T, Gores F, et al. Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography. Eur J Pharm Biopharm 2005;60:391–9
   PubMed Web of Science ®Google Scholar
• Joshi SA, Chavhan SS, Sawant KK. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur J Pharm Biopharm 2010;76:189–99
   PubMed Web of Science ®Google Scholar
• Musumeci T, Ventura CA, Carbone C, et al. Effects of external phase on D-cycloserine loaded W/O nanocapsules prepared by the interfacial polymerization method. Eur J Med Chem 2011;46:2828–34
   PubMed Web of Science ®Google Scholar
• Xiao J, Li XZ, Liu S, Lei P. Preparation of oleanolic acid loaded polybutylcyanoacrylate nanocapsules by interfacial polymerization. Chin Pharm 2006;20:1551–4
   Google Scholar
• Ren F, Chen R, Wang Y, et al. Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer. Pharm Res 2011;28:897–906
   PubMed Web of Science ®Google Scholar
• Limouzin C, Caviggia A, Ganachaud F, et al. Anionic polymerization of n-butyl cyanoacrylate in emulsion and miniemulsion. Macromolecules 2003;36:667–74
   Web of Science ®Google Scholar
• Huang CY, Chen CM, Lee YD. Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion. Int J Pharm 2007;338:267–75
   PubMed Web of Science ®Google Scholar
• He M, Zhao Z, Yin L, et al. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. Int J Pharm 2009;373:165–73
   PubMed Web of Science ®Google Scholar
• He W, Jiang X, Zhang ZR. Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin. J Pharm Sci 2008;97:2250–9
   PubMed Web of Science ®Google Scholar
• Yordanov GG, Dushkin CD. Preparation of poly(butylcyanoacrylate) drug carriers by nanoprecipitation using a pre-synthesized polymer and different colloidal stabilizers. Colloid Polym Sci 2010;288:1019–26
   Web of Science ®Google Scholar
• Mitra A, Lin S. Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems. J Pharm Pharmacol 2003;55:895–902
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen J, Zhang B, et al. Polybutylcyanoacrylate nanoparticles as novel vectors in cancer gene therapy. Nanomedicine 2007;3:144–53
   PubMed Web of Science ®Google Scholar
• Duan J, Mansour HM, Zhang Y, et al. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm 2012;426:193–201
   PubMed Web of Science ®Google Scholar
• Li N, Wang J, Yang X, et al. Novel nanogels as drug delivery systems for poorly soluble anticancer drugs. Colloids Surf B Biointerfaces 2011;83:237–44
   PubMed Web of Science ®Google Scholar
• Reimold I, Domke D, Bender J, et al. Delivery of nanoparticles to the brain detected by fluorescence microscopy. Eur J Pharm Biopharm 2008;70:627–32
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu S, Yin L, et al. Preparation, characterization and biocompatibility of poly(ethylene glycol)-poly(n-butyl cyanoacrylate) nanocapsules with oil core via miniemulsion polymerization. Eur Polym J 2008;44:1654–61
   Web of Science ®Google Scholar
• Yordanov G, Skrobanska R, Evangelatov A. Entrapment of epirubicin in poly(butyl cyanoacrylate) colloidal nanospheres by nanoprecipitation: formulation development and in vitro studies on cancer cell lines. Colloid Surf B Biointerfaces 2012;92:98–105
   PubMed Web of Science ®Google Scholar
• Gaumet M, Vargas A, Gurny R, et al. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 2008;69:1–9
   PubMed Web of Science ®Google Scholar
• Win KY, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005;26:2713–22
   PubMed Web of Science ®Google Scholar
• Gao K, Jiang X. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Int J Pharm 2006;310:213–19
   PubMed Web of Science ®Google Scholar
• Arias JL, Linares-Molinero F, Gallardo V, et al. Study of carbonyl iron/poly(butylcyanoacrylate) (core/shell) particles as anticancer drug delivery systems Loading and release properties. Eur J Pharm Sci 2008;33:252–61
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001;53:283–318
   PubMed Web of Science ®Google Scholar
• Moghimi SM. Exploiting bone marrow microvascular structure for drug delivery and future therapies. Adv Drug Deliv Rev 1995;17:61–73
   Web of Science ®Google Scholar
• Labouta HI, Schneider M. Interaction of inorganic nanoparticles with the skin barrier: current status and critical review. Nanomedicine 2013;9:39–54
   PubMed Web of Science ®Google Scholar
• Zhang ZM, Yang XY, Deng SH, et al. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice. Chin Med J (Engl) 2007;120:1336–42
   PubMed Web of Science ®Google Scholar
• Kaparissides C AS, Kotti K, Chaitidou S. Recent advances in novel drug delivery systems. Int J PharmTech Res 2010;2:2025–7
   Google Scholar
• Yordanov G. Poly(alkyl cyanoacrylate) nanoparticles as drug carriers: 33 years later. Bulgarian J Chem 2012;1:61–72
   Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, et al. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1–20
   PubMed Web of Science ®Google Scholar
• Das D, Lin S. Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration. J Pharm Sci 2005;94:1343–53
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010;75:1–18
   PubMed Web of Science ®Google Scholar
• Vauthier C, Dubernet C, Fattal E, et al. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev 2003;55:519–48
   PubMed Web of Science ®Google Scholar
• Zhang XN, Gong JH, Tang LH, et al. Studies on the drug-loading mechanism of polybutylcyanocrylate nanoparticle and its stability of thermodynamics. Curr Nanosci 2008;4:59–61
   Web of Science ®Google Scholar
• Ruiz A, Salas G, Calero M, et al. Short-chain PEG molecules strongly bound to magnetic nanoparticle for MRI long circulating agents. Acta Biomater 2013;9:6421–30
   PubMed Web of Science ®Google Scholar
• Brasnjevic I, Steinbusch HW, Schmitz C, et al. Delivery of peptide and protein drugs over the blood-brain barrier. Prog Neurobiol 2009;87:212–51
   PubMed Web of Science ®Google Scholar
• Cai Z, Wang Y, Zhu LJ, et al. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Curr Drug Metab 2010;11:197–207
   PubMed Web of Science ®Google Scholar
• Chaudhari KR, Ukawala M, Manjappa AS, et al. Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery carrier. Pharm Res 2012;29:53–68
   PubMed Web of Science ®Google Scholar
• Troster SD, Muller U, Kreuter J. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants. Int J Pharm 1990;61:85–100
   Web of Science ®Google Scholar
• Alyautdin RN, Tezikov EB, Ramge P, et al. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. J Microencapsul 1998;15:67–74
   PubMed Web of Science ®Google Scholar
• Aliautdin RN, Kreuter J, Kharkevich DA. Drug delivery to the brain with nanoparticles. Eksp Klin Farmakol 2003;66:65–8
   PubMedGoogle Scholar
• Weiss CK, Kohnle MV, Landfester K, et al. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation. Chem Med Chem 2008;3:1395–403
   Web of Science ®Google Scholar
• Kreuter J, Ramge P, Petrov V, et al. Direct evidence that polysorbate-80-coated poly(Butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res 2003;20:409–16
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Santhi K, et al. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. Eur J Pharm Biopharm 2008;70:75–84
   PubMed Web of Science ®Google Scholar
• Kreuter J, Gelperina S. Use of nanoparticles for cerebral cancer. Tumori 2008;94:271–7
   PubMed Web of Science ®Google Scholar
• Koffie RM, Farrar CT, Saidi LJ, et al. Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging. Proc Natl Acad Sci USA 2011;108:18837–42
   PubMed Web of Science ®Google Scholar
• Pietkiewicz J, Zielinska K, Saczko J, et al. New approach to hydrophobic cyanine-type photosensitizer delivery using polymeric oil-cored nanocarriers: hemolytic activity, in vitro cytotoxicity and localization in cancer cells. Eur J Pharm Sci 2010;39:322–35
   PubMed Web of Science ®Google Scholar
• Rempe R, Cramer S, Huwel S, et al. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity. Biochem Biophys Res Commun 2011;406:64–9
   PubMed Web of Science ®Google Scholar
• Kreuter J, Alyautdin RN, Kharkevich DA, et al. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res 1995;674:171–4
   PubMed Web of Science ®Google Scholar
• Kurakhmaeva KB, Djindjikhashvili IA, Petrov VE, et al. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles. J Drug Target 2009;17:564–74
   PubMed Web of Science ®Google Scholar
• Ambruosi A, Yamamoto H, Kreuter J. Body distribution of polysorbate80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats. J Drug Target 2005;13:535–42
   PubMed Web of Science ®Google Scholar
• Kuo YC, Chung CY. Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells. Colloids Surf B Biointerfaces 2012;91:242–9
   PubMed Web of Science ®Google Scholar
• Hepp Y, Tano MC, Pedreira ME, et al. NMDA-like receptors in the nervous system of the crab Neohelice granulata: a neuroanatomical description. J Comp Neurol 2013;521:2279–97
   PubMed Web of Science ®Google Scholar
• Reukov V, Maximov V, Vertegel A. Proteins conjugated to poly(butyl cyanoacrylate) nanoparticles as potential neuroprotective agents. Biotech Bioeng 2010;108:243–52
   Web of Science ®Google Scholar
• Yilmaz-Aydogan H, Kurnaz O, Kucukhuseyin O, et al. Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes. Gene 2013;523:20–6
   PubMed Web of Science ®Google Scholar
• Mulik RS, Monkkonen J, Juvonen RO, et al. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells. Int J Pharm 2012;437:29–41
   PubMed Web of Science ®Google Scholar
• Lee M-Y, Park S-J, Park K, et al. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. ACS Nano 2011;5:6138–47
   PubMed Web of Science ®Google Scholar
• Rivkin I, Cohen K, Koffler J, et al. Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors. Biomaterials 2010;31:7106–14
   PubMed Web of Science ®Google Scholar
• Winn SR, Hu Y, Sfeir C, et al. Gene therapy approaches for modulating bone regeneration. Adv Drug Deliv Rev 2000;42:121–38
   PubMed Web of Science ®Google Scholar
• Maitani YHY. Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther 2005;12:796–809
   PubMed Web of Science ®Google Scholar
• Lai CM, Lai YK, Rakoczy PE. Adenovirus and adeno-associated virus vectors. DNA Cell Biol 2002;21:895–913
   PubMed Web of Science ®Google Scholar
• Chavany C, Doan T, Couvreur P, et al. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides. Pharm Res 1992;9:441–9
   PubMed Web of Science ®Google Scholar
• El-Shabouri MH. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharma 2002;249:101–8
   PubMed Web of Science ®Google Scholar
• Chung T-H, Wu S-H, Yao M, et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 2007;28:2959–66
   PubMed Web of Science ®Google Scholar
• Gan Q, Wang T, Cochrane C, et al. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 2005;44:65–73
   PubMed Web of Science ®Google Scholar
• Duan J, Zhang Y, Han S, et al. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm 2010;400:211–20
   PubMed Web of Science ®Google Scholar
• Artursson P, Lindmark T, Davis S, et al. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 1994;11:1358–61
   PubMed Web of Science ®Google Scholar
• Yang SC, Ge HX, Hu Y, et al. Formation of positively charged poly(butyl cyanoacrylate) nanoparticles stabilized with chitosan. Colloid Polym Sci 2000;278:285–92
   Web of Science ®Google Scholar
• Kafedjiiski K, Foger F, Werle M, et al. Synthesis and in vitro evaluation of a novel chitosan-glutathione conjugate. Pharml Res 2005;22:1480–8
   PubMed Web of Science ®Google Scholar
• Maiti S, Chatterji PR. Aggregation and polymerization of amphiphilic macromonomers with a double bond at the hydrophilic terminal. J Colloid Interface Sci 2000;232:273–81
   PubMed Web of Science ®Google Scholar
• Sun X, Wu F, Lu W, et al. Sustained-release hydroxycamptothecin polybutylcyanoacrylate nanoparticles as a liver targeting drug delivery system. Pharmazie 2004;59:791–4
   PubMed Web of Science ®Google Scholar
• Zhang ZR, Lu W. Study on liver targeting and sustained release hydroxycamptothecin polybutylcyanoacrylate nanoparticles. Yao Xue Xue Bao 1997;32:222–7
   PubMedGoogle Scholar
• Zhang XN, Zhang Q, Wen H, et al. Preparation of albendazole polybutycyanocrylate nanoparticles and study on its pharmaceutical properties and tissue distribution. Yao Xue Xue Bao 2003;38:462–6
   PubMedGoogle Scholar
• Mornet S, Vasseur S, Grasset F, et al. Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 2004;14:2161–75
   Web of Science ®Google Scholar
• Arias JL, Gallardo V, Linares-Molinero F, et al. Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles. J Colloid Interface Sci 2006;299:599–607
   PubMed Web of Science ®Google Scholar
• Alexiou C, Schmidt A, Klein R, et al. Magnetic drug targeting: biodistribution and dependency on magnetic field strength. J Magn Magn Mater 2002;252:363–6
   Web of Science ®Google Scholar
• Cai L, Niu G, Hu Z, et al. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin. J Drug Target 2009;17:200–6
   PubMed Web of Science ®Google Scholar
• Dobson J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther 2006;13:283–7
   PubMed Web of Science ®Google Scholar
• Zhou Q, Sun X, Zeng L, et al. A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma. Nanomed Nanotechnol Biol Med 2009;5:419–23
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387–92
   PubMed Web of Science ®Google Scholar
• Lockman PR, Mumper RJ, Khan MA, et al. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm 2002;28:1–13
   PubMed Web of Science ®Google Scholar
• Gunaseelan S, Gunaseelan K, Deshmukh M, et al. Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs. Adv Drug Deliv Rev 2010;62:518–31
   PubMed Web of Science ®Google Scholar
• Fahmy T, Fong P, Park J, et al. Nanosystems for simultaneous imaging and drug delivery to T cells. AAPS J 2007;9:E171–80
   PubMed Web of Science ®Google Scholar
• Liu H, Chen J. Indomethacin-loaded poly(butylcyanoacrylate) nanoparticles: preparation and characterization. PDA J Pharm Sc Tech 2009;63:207–16
   PubMedGoogle Scholar
• Alyautdin R, Gothier D, Petrov V, et al. Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles. Eur J Pharm Biopharm 1995;41:44–8
   Web of Science ®Google Scholar
• Kuo YC, Chen HH. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier. Int J Pharm 2006;327:160–9
   PubMed Web of Science ®Google Scholar
• Yang YX, Zhu L, He X, et al. Antitumor activity of mitoxantrone-nanosphere against murine liver tumor H22. Sichuan Da Xue Xue Bao Yi Xue Ban 2004;35:68–70
   PubMedGoogle Scholar
• Chaudhari KR, Kumar A, Khandelwal VKM, et al. Targeting efficiency and biodistribution of zoledronate conjugated docetaxel loaded pegylated PBCA nanoparticles for bone metastasis. Adv Funct Mater 2012;22:4101–14
   Web of Science ®Google Scholar
• BaoPing LYOWMSY. Preparation of vinblastine nanoparticles and its anti-tumor effect. J Shanghai Jiaotong Univ 2008;26:228–32
   Google Scholar
• Lu B, Feng JF, Yang XC. Human recombinant interferon-alpha 2a polybutylcyanoacrylate sustained release lyophilized nanospheres for liver-targeting. Sichuan Da Xue Xue Bao Yi Xue Ban 2004;35:1–4
   PubMedGoogle Scholar
• Mulik RS, Monkkonen J, Juvonen RO, et al. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model. Mol Pharm 2010;7:815–25
   PubMed Web of Science ®Google Scholar
• Tian X, Lin XN, Wei F, et al. Preparation of temozolomide-loaded polybutylcyanoacrylate nanoparticles. Chin J Hosp Pharm 2011;31:1689–93
   Google Scholar
• Xi-Xiao Y, Jan-Hai C, Shi-Ting L, et al. Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor. Regul Toxicol Pharmacol 2006;46:211–17
   PubMed Web of Science ®Google Scholar
• Wohlfart S, Khalansky AS, Gelperina S, et al. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier. J Control Release 2011;154:103–7
   PubMed Web of Science ®Google Scholar
• Kisich KO, Gelperina S, Higgins MP, et al. Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis. Int J Pharm 2007;345:154–62
   PubMed Web of Science ®Google Scholar
• Luo DQ, Guo JH, Wang FJ, et al. Anti-fungal efficacy of polybutylcyanoacrylate nanoparticles of allicin and comparison with pure allicin. J Biomater Sci Polym Ed 2009;20:21–31
   PubMed Web of Science ®Google Scholar
• Xu N, Gu J, Zhu Y, et al. Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice. Int J Nanomedicine 2011;6:905–13
   PubMed Web of Science ®Google Scholar
• Zhang ZR, He Q. Study on liver targeting and hepatocytes permeable valaciclovir polybutylcyanoacrylate nanoparticles. World J Gastroenterol 1999;5:330–3
   PubMed Web of Science ®Google Scholar
• Wilk KA, Zielinska K, Pietkiewicz J, et al. Photo-oxidative action in MCF-7 cancer cells induced by hydrophobic cyanines loaded in biodegradable microemulsion-templated nanocapsules. Int J Oncol 2012;41:105–16
   PubMed Web of Science ®Google Scholar
• Fokong S, Theek B, Wu Z, et al. Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles. J Control Release 2012;163:75–81
   PubMed Web of Science ®Google Scholar
• Liu Z, Lammers T, Ehling J, et al. Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 2011;32:6155–63
   PubMed Web of Science ®Google Scholar
• Mo R, Sun Q, Xue J, et al. Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery. Adv Mater 2012;24:3659–65
   PubMed Web of Science ®Google Scholar